#65 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Older adults represent a growing market for dispensaries but present clinical challenges due to limited safety data, drug-drug interactions, and age-related pharmacokinetic changes that clinicians must understand to counsel patients appropriately. This demographic shift requires physicians to develop evidence-based guidelines for cannabis dosing and monitoring in elderly patients, particularly those on multiple medications or with cognitive or fall risk concerns. Clinicians need training on cannabinoid pharmacology and state medical marijuana programs to provide informed recommendations and reduce potential adverse outcomes in this vulnerable population.
This article highlights the growing demographic of older adults obtaining medical cannabis cards and increasing their consumption patterns, which represents a significant market opportunity for dispensaries but raises clinical concerns for healthcare providers. Older patients, exemplified by users consuming 40-50 mg daily through multiple product forms, may be at heightened risk for adverse effects including cognitive impairment, falls, drug interactions, and cannabinoid hyperemesis syndrome due to age-related pharmacokinetic changes and polypharmacy. The expansion of medical cannabis legalization has created a situation where older adults can access cannabis without necessarily consulting their primary care physicians or geriatricians, potentially leading to unmonitored use and inadequate assessment of risks versus benefits in this vulnerable population. Unlike traditional pharmaceuticals, cannabis products lack standardized dosing guidance and clear efficacy data for common geriatric conditions, making it difficult for physicians to counsel patients on appropriate use or monitor for harms. Clinicians caring for older adults should proactively screen for cannabis use at each visit, understand the pharmacology and potential interactions with common medications, and engage in shared decision-making conversations about safer alternatives when appropriate. Given the gap between dispensary promotion and medical oversight, physicians need to take an active role in educating older patients about dosing safety and monitoring their cannabis consumption as part of comprehensive medication management.
“We’re seeing a real clinical problem: older patients are self-titrating to doses that would concern me in younger populations, partly because dispensaries have financial incentives to support higher consumption rather than help them find their minimum effective dose. My job is to help seniors use cannabis safely and effectively, which often means starting low, going slow, and teaching them that more isn’t always better for pain or sleep.”
💊 The increasing prevalence of cannabis use among older adults presents a significant clinical challenge as this population seeks alternatives to conventional medications, particularly for pain and anxiety management. While dispensaries benefit from this growing market segment, healthcare providers must contend with several important concerns, including the lack of standardized dosing guidance, limited evidence for safety and efficacy in geriatric populations, and potential drug-drug interactions with the polypharmacy common in this age group. High daily doses like those mentioned in patient reports carry particular risks for older adults, who may experience impaired cognition, falls, orthostatic hypotension, and other adverse effects at lower thresholds than younger users. The gap between patient autonomy in obtaining cannabis through legal channels and clinician knowledge about its effects creates opportunities for suboptimal care and delayed recognition of cannabis-related complications. Healthcare providers should proactively inquire about cannabis use in older patients, counsel on dosing caution, monitor
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: